This is actually a great opportunity for Admedus to turn the tables on the German competitors that funded the study.... Not only is the study able to be discredited very quickly it can then be turned on the weasels who sponsored it to show them in their true light! The study, instead of diminishing Admedus, could be very effectively used to discredit competitor X as a company which will stoop to dirty tricks and sophistry to gain an advantage.... This is not a company you'd want to be dealing with! Attack is the best form of defense!
This is actually a great opportunity for Admedus to turn the...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |